Styrenyl derivative compounds for treating ophthalmic diseases and disorders
US10201545B2 · kind B2 · utility
0Cited by
15References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 2015 |
| Grant date | Feb 12, 2019 |
| Priority date | — |
| Expiry date | Feb 25, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are styrenyl derivative compounds, including but not limited to stilbene derivative compounds, and compositions comprising these compounds, that are useful for treating and preventing ophthalmic diseases and disorders, including age-related macular degeneration (AMD) and Stargardt's Disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.